Market Report Summary
- Market – Animal Drug Compounding Market
- Market Value – US$ 380 Mn in 2024
- Market CAGR Value – 7% in 2024
- Market Forecast Year – 2020 to 2030
For Full Information -> Click Here
Read Full Press Release Below
Global demand for animal drug compounding is expected to significantly increase, owing to the unavailability of FDA-approved animal drugs. Compounded prescriptions for animal species are considered to be significantly higher than those for branded prescription drugs.
For instance, in 2017, the U.S. FDA estimated that, 75,000 pharmacies in the U.S. fill 6,350,000 animal compounding prescriptions.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12871
- Hoye’s Pharmacy
- Vertisis Custom Pharmacy
- Smith Caldwell Drug Store
- Sixth Avenue Medical Pharmacy
- Dougherty’s Pharmacy
- Triangle Compounding Pharmacy Inc.
- Medisca Inc.
- Wedgewood Pharmacy
- Millers Pharmacy
- Chiron Compounding Pharmacy
- MEDS Canadian Compounding Pharmacy
- Aurora Compounding
- Pace Pharmacy
- Victoria Compounding Pharmacy
- Pratt’s Compounding Pharmacy
- People’s Choice Pharmacy
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12871
Persistence Market Research predicts that, the global animal drug compounding market would be valued at US$ 1.5 Bn in 2019, and will expand at an 8% CAGR over the forecast period (2019-2029).
Key Takeaways of Animal Drug Compounding Market Study
Hormonal drugs, manipulating the emotions and moods of pets, are expected to gain traction during the forecast period.
Increasing adoption of companion animals is expected to contribute to significant dominance of the segment during the forecast period.
Orally formulation of drugs is expected to hold more than 80% of the global animal drug compounding market share by the end of 2029.
In terms of formulation, the injectable segment is expected to grow 1.6X by the end of 2029.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/12871
Leading medical & pharmaceutical companies are collaborating with small compounding solution providers, hospitals, and research facilities to strengthen their market position.
North America is expected to dominate the global animal drug compounding market, owing to increasing adoption of compounded medication with alternate dosage forms and added flavors.
“Unavailability of generic medications for animals in desired dosage forms is pushing the production of compounded drugs, thus driving the growth of the animal drug compounding market during the forecast period”, says a PMR analyst.
CNS Drugs Dominating Animal Drug Compounding Market
Central nervous system inflammation is the most common cause of neurological disorders in dogs and cats. Abnormal limb coordination, seizures, behavioural changes, and blindness are cited as the most common abnormalities in dogs and cats with central nervous system inflammation.
For instance, according to the International Journal of Pharmaceutical Compounding, central nervous system drugs were the most commonly dispensed medications from animal drug compounding pharmacies with approximately 39% of the total veterinary prescriptions.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the animal drug compounding market in its latest study, presenting historical demand assessment from 2014-2018 and projections from 2019-2029, on the basis of product type (CNS agents, anti-infective agents, hormones and substitutes, anti-inflammatory agents, others), animal type (companion animals and livestock), formulation (oral, injectable, and others), across seven key regions.
Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com